KURA
Kura Oncology Inc.
Company Overview
| Mkt Cap | $785.51M | Price | $10.27 |
| Volume | 1.67M | Change | -1.63% |
| P/E Ratio | -4.5 | Open | $10.48 |
| Revenue | $53.9M | Prev Close | $10.44 |
| Net Income | $-174.0M | 52W Range | $5.41 - $19.73 |
| Div Yield | N/A | Target | $27.00 |
| Overall | 52 | Value | 60 |
| Quality | 31 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyKura Oncology Inc. (KURA) is a leading Healthcare company in the Biotechnology industry, currently trading at $10.27 with a market capitalization of $785.51 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows KURA with a volume of 1.67 million shares. The stock opened up 0.38% from yesterday's close of $10.44. Current analyst estimates project earnings of $-2.07 per share for this year, with next year targeting $-1.78.
KURA demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for KURA include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 162.9%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:41 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KURA | $10.27 | -1.6% | 1.67M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |